Beyond the US, however, investment patterns have been far more consistent. Europe, Asia, and the rest of the world all saw broadly stable levels of capital deployed, with year-on-year changes ...

Wyss Zurich was founded to pave the way from basic research to the market. Its ten-year track record shows that it has been ...

ZenOwn’s solutions are already deployed across 23 brands in 31 countries. With CHF 50,000 in FIF Seed Digital funding, the company will accelerate hiring and enterprise integrations, supporting the ...

The end of the year is always hectic in the start-up scene. But the numerous news items in recent weeks could also point to a slow end to the funding crisis.

Twenty innovation partnerships between startups and corporates have been established in the 10th edition of Kickstart. Six Swiss startups will collaborate with some of Switzerland’s industry players ...

Based in Lugano, NNAISENSE has built a generative AI framework for financial markets to enable the prediction of coherent market scenarios across multiple asset classes, data sources and modalities.

Based in Allschwil (Baselland), GlioCART is developing a new type of cell therapy – the first CAR-T cell therapy – designed to target both glioblastoma tumors and the surrounding immune-suppressive ...

Motley has launched its AI-powered business reporting platform designed to automate and streamline business reporting, allowing teams to transform data into actionable documents and presentations in ...

Zürcher Kantonalbank announced the first closing of its second Swiss Growth Fund. In the eight months since the start of the capital raising process, capital commitments of CHF 171.65 million have ...

After two years of collaborative testing across more than 15 food applications, Denmark-based Oterra, a global leader in natural food colors has entered a commercial agreement with Seprify to ...

GreenTriangle will gradually be integrated into the “Claims Tech & Services” division, under the international leadership of José Piñera, international director of the Saretec group. This division is ...

Schlieren-based Virometix, the company pioneering fully synthetic vaccines to generate targeted and protective immune responses against infectious diseases and cancer, has secured $15 million in a ...